# Tempest Therapeutics, Inc.: Form 8-K, filed Feb 7, 2019

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 8-K
- Filed: 2019-02-07
- Accepted by EDGAR: Feb 7, 2019, 17:27 ET
- Period: 2019-02-01
- Accession: 0001104659-19-006384
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000110465919006384/a19-4137_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000110465919006384/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000110465919006384/a19-4137_18k.htm

Filed Feb 7, 2019.
Source: SEC EDGAR, the filing index for accession 0001104659-19-006384. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
